Beta-Ketothiolase Deficiency as A Treatable Neurometabolic Disorder: A Case Report Due to A Novel Compound Heterozygote Mutations in ACAT1 Gene
Published: 1 March 2019
Biomedical Journal of Scientific & Technical Research , Volume 15, pp 1-4; https://doi.org/10.26717/bjstr.2019.15.002697
Abstract: 2-methylacetoacetyl CoA thiolase enzyme acts at the end stage of isoleucine amino acid catabolism pathway and is involved in the ketone body metabolism  (Figure 1).
Keywords: Amino acid / Body Metabolism / Enzyme Acts / Heterozygote Mutations / Neurometabolic Disorder / Methylacetoacetyl Coa / Report Due / Beta Ketothiolase / Isoleucine Amino / thiolase enzyme
Scifeed alert for new publicationsNever miss any articles matching your research from any publisher
- Get alerts for new papers matching your research
- Find out the new papers from selected authors
- Updated daily for 49'000+ journals and 6000+ publishers
- Define your Scifeed now
Click here to see the statistics on "Biomedical Journal of Scientific & Technical Research" .